Careall Triple Antibiotic Ointment
FDA Label NDC 51824-117

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by New World Imports, Inc for the product Careall Triple Antibiotic (NDC 51824-117). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each gram), otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients (In Each Gram)

Bacitracin Zinc 400 units

Neomycin Sulfate 5 mg

Polymyxin B Sulfate 5,000 units

Otc - Purpose

First aid antibiotic

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a poison control center immediately

Indications & Usage

First aid to help prevent infection in minor cuts, scrapes and burns

Warnings

For external use only

Do not use

In the eyes

If you are allergic to any of the ingredients

Over large areas of the body

Ask a doctor before use if you have

Animal bites

Serious Burns

Deep or puncture wounds

Stop use and ask a doctor if

You need to use longer than 1 week

condition persists or gets worse

rash or other allergic reaction develops

Dosage & Administration

Clean the affected area

Apply a small amount of this product (an amount equal to the surface of th tip of a finger) on the area 1 to 3 times daily

May be covered with a sterile bandage

Inactive Ingredient

White Petrolatum

Package Label.Principal Display Panel

Pdp (Ta01)

Pdp (Ta01)

Pdp (Tao144)

Pdp (Tao144)

Pdp (Ta025)

Pdp (Ta025)

Pdp (Tao11)

Pdp (Tao11)

* Please review the disclaimer below.